The largest database of trusted experimental protocols

6 protocols using sirna duplex

1

Modulating TCTP Expression via siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A small interfering RNA (siRNA) duplex targeting TCTP (5′-GAAATCAATCAAAGGGAAA-3′) and a nonsilencing control siRNA duplex were synthesized by RIBOBIO (Guangzhou, China). A TCTP expression plasmid and a control plasmid were purchased from Origene (Beijing, China). Cells were cultured in antibiotic-free medium for 2 hours. They were then transfected with TCTP siRNA (50 nM) or TCTP plasmid DNA (2.5 ng/ul) using Lipofectamine 2000 (Invitrogen, USA). Silencing was evaluated 40 hours after transfection by western blot. TCTP overexpression was evaluated 24 hours after transfection by western blot.
+ Open protocol
+ Expand
2

Modulating hiPSC-CM Contractility via siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A small interfering RNA (siRNA) duplex against PLN or ANK2 was designed and constructed by Ribobio (Guangdong, China). Next, hiPSC-CMs were transfected with siRNA at a final concentration of 100 nM using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s instruction. A non-matching siRNA was used as a negative control. After siRNA transfection for 48 h, the cells were then incubated with SNT (3 µM) for 24 h. Cellular contractility was then determined by CardioExcyte 96 apparatus.
+ Open protocol
+ Expand
3

Targeting HDAC1-3 Modulates p75NTR and Histone Acetylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDAC1, HDAC2, and HDAC3 siRNA duplex (Guangzhou RIBOBIO CO, LTD) were used to interfere with endogenous HDAC1, HDAC2 and HDAC3 mRNA levels, respectively. Cells were seeded in six-well culture microplates at a density of 1 × 105 cells/well in 2 ml of antibiotic-free normal growth medium. The following day, cells were transfected with 50 nM siRNA duplex and 12 μl of siRNA transfection reagent (Guangzhou RIBOBIO CO, LTD) mixed in DMEM/F12 (1:1) media with 1% fetal bovine serum. The transfected cells were incubated at 37°C for 24 h. Untreated cells and non-specific siRNA (scrambled siRNA; Guangzhou RIBOBIO CO, LTD) were used as controls. The interference efficiency was evaluated by qRT-PCR and western blot analyses. In addition, the expression levels of p75NTR mRNA and protein, and Ace-H3K9 and Ace-H4K12 levels were investigated by the above methods. This experiment was performed in duplicate and repeated three times.
+ Open protocol
+ Expand
4

Lipid-based siRNA Delivery System

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,2-Distearoyl-sn-glycero-3-phosphatidylcholine (DSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[meth-oxy(polyethyleneglycol)-2000] (DSPEPEG2000), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[meth-oxy (polyethyleneglycol)-2000-folate (DSPE-PEG2000-folate)], and cholesterol were purchased from Avanti Polar Lipids, China. Pluronic F68, calcium chloride, and sodium phosphate were purchased from Sigma-Aldrich. A siRNA duplex was designed by Guangzhou RiboBio Co., Ltd. (Guangzhou, People’s Republic of China). It is a 21 bp double-stranded RNA oligos with dTdT 3′ overhangs and has sequences as follows: (sense) 5′-GGACAUAUGAGACCUUCAAdTdT-3′; and (antisense) 5′ UUGAAGGUCUCAUAUGUCCdTdT-3′.
+ Open protocol
+ Expand
5

Silencing HDAC1, 2, and 3 in SH-SY5Y cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDAC1, 2, and 3 small-interfering RNA (siRNA) duplexes (Guangzhou RiboBio Co, Ltd, China) were used simultaneously (si-HDAC1-2-3) or singly (si-HDACs) to interfere with endogenous HDAC1, HDAC2, and HDAC3 expression. The siRNA oligos were as follows: HDAC1: 5′-CCGGTCATGTCCAAAGTAA-3′; HDAC2: 5′-TCCGTAATGTTGCTCGATG-3′; and HDAC3: 5′-GCATTGATGACCAGAGTTA-3′. In brief, differentiated SH-SY5Y cells were seeded in 6-well culture microplates at a density of 1 × 105 cells/well in 2 mL of antibiotic-free normal growth medium. The following day, cells were transfected with a solution of 50 nmol/L siRNA duplex and 12 μL of siRNA transfection reagent (Guangzhou RiboBio Co, Ltd) mixed in DMEM/F12 medium containing 10% FBS. The transfected cells were incubated at 37°C for 24 hours. The untreated (non-siRNA) and nonspecific siRNA treated (scrambled siRNA; Guangzhou RiboBio Co, Ltd) cells were used as controls. The interference efficiency was evaluated by qRT-PCR and Western blot analyses. In addition, the expression levels of TrkA mRNA and protein were investigated by the above methods. This experiment was performed in duplicate and repeated 3 times.
+ Open protocol
+ Expand
6

HEK293 and hiPSC-CM Co-Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal calf serum (Gibco) with 5% CO2 at 37°C. The HEK293 cells were transiently co‐transfected with Kv4.3 (or Kv4.2), KChIP2, and DPP6 plasmid using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. The green fluorescent protein (GFP) was used as a reporter. The human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs, 50‐60 days of maturity; Cellapybio, Beijing, China) were maintained in serum‐free medium (Cellapybio) on 24‐well dishes coated with Matrigel Matrix (BD‐Biocoat, Corning, USA) with 5% CO2 at 37°C. The small interfering RNA (siRNA) duplex against the human DPP6 gene (NM_130797, 5′‐GGTCCATCATCGGCTCTTT‐3′) was designed and constructed by Ribobio (Guangdong, China). hiPSC‐CMs were transfected with siRNA using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s instruction at a final siRNA concentration of 100 nM. A non‐matching siRNA was used as a negative control. Cells were used for experiments 48 hours after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!